InvestorsHub Logo
Followers 11
Posts 600
Boards Moderated 0
Alias Born 12/13/2016

Re: None

Wednesday, 09/13/2017 9:30:41 AM

Wednesday, September 13, 2017 9:30:41 AM

Post# of 7464
Hats off to CNBX. Very few stocks have the ability to have 100% successful clinical studies across all cancers tested, cause apoptosis of cancerous cells while not damaging normal cells, have product in the market, have a major influx of investor cash, be featured in Rolling Stone Magazine, and still stay at around one dollar a share while companies like GWPH that do not have articles in Rolling Stone and most people have never heard of are trading at $ 109.

Kudos to CNBX for staying so humble!!!